AOD9604 5mg

Kuvaus

AOD9604 5 mg – Fragment of Human Growth Hormone for Fat Metabolism Research

Koostumus: 5 mg AOD9604 (lyophilized peptide powder)
Kategoria: Peptidi
Lomake: Injektiopullo, jossa on kylmäkuivattua jauhetta
Hallinto: Ihonalainen injektio sen jälkeen, kun se on saatettu bakteriostaattiseen veteen

What is AOD9604?

AOD9604 is a modified fragment of human growth hormone (HGH), specifically the 176–191 amino acid sequence, developed to target fat metabolism without the typical systemic hormonal effects of HGH.
It functions by stimulating lipolysis and inhibiting lipogenesis in adipose tissue, making it a leading compound in obesity, energy regulation, and metabolic research.

In preclinical and experimental studies, AOD9604 has shown promising potential in enhancing fat breakdown, improving energy utilization, and supporting overall metabolic balance.

➡️ Ideal for studies on fat oxidation, metabolic rate enhancement, and adipose tissue regulation.

Tärkeimmät tutkimustulokset

Fat Breakdown: Stimulates the breakdown of stored fat and increases the release of fatty acids.

Anti-Lipogenesis: Demonstrated to inhibit the formation of new fat cells in experimental models.

Metabolic Support: May improve overall energy expenditure and metabolic rate.

No HGH-Like Side Effects: As a non-hormonal fragment, it does not activate IGF-1 or cause typical HGH-mediated actions.

Tissue Targeted: Designed for selective action on adipose tissue with minimal systemic activity.

Annostus ja käyttö

Rekonstruoidaan bakteriostaattisella vedellä ennen käyttöä.

Typical research range: 300–500 mcg per application, subcutaneously, 1–2 times daily depending on study protocol.

Säilytä rekonstruoitu liuos jääkaapissa ja käytä 30 päivän kuluessa.

Säilytysohjeet

Store at 2–8 C (36–46 F)
Suojaa valolta ja kosteudelta
Ei saa jäädyttää
Vältä lämpötilan vaihteluita

Why Choose AOD9604?

AOD9604 is a highly regarded research fragment derived from HGH, engineered to focus exclusively on fat metabolism.
Its selective mechanism, strong preclinical data, and lack of hormonal IGF-1 activity make it a preferred compound in metabolic and obesity research.

Tutkitaan mahdollisuuksia AOD9604 5 mg for advanced studies in fat loss mechanisms and metabolic health.